Moritz Kaposi General Hospital
About Moritz Kaposi General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Moritz Kaposi General Hospital
During the past decade, Moritz Kaposi General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
2004-09-01
2005-10-01
Completed
947
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
2003-04-01
2005-12-01
Completed
885
Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis
2003-02-01
2005-03-01
Completed
138
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
2006-12-01
2010-03-01
Completed
819
A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
2007-06-19
2018-05-17
Completed
131
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
2007-09-01
2008-11-01
Terminated
150
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
2008-02-01
2009-04-01
Completed
253
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Moritz Kaposi General Hospital
According to Clinical.Site data, the most researched conditions in "Moritz Kaposi General Hospital" are
"Coronary Artery Disease" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Grade 3 Lymphoma" (1 trials) and "de Novo DLBCL" (1 trials). Many other conditions were trialed in "Moritz Kaposi General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Moritz Kaposi General Hospital
Most popular intervention types in "Moritz Kaposi General Hospital" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine + Rituximab" (1 trials) and "Pixantrone + Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Moritz Kaposi General Hospital
The vast majority of trials in "Moritz Kaposi General Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Moritz Kaposi General Hospital
Currently, there are NaN active trials in "Moritz Kaposi General Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Moritz Kaposi General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Moritz Kaposi General Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".